Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00497003Phase 4Completed
A Phase 4 trial of carvedilol in chronic heart failure (CHF), type 2 diabetes mellitus (T2DM), sponsored by Bispebjerg and Frederiksberg Hospital. Started Feb 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00497003.